Non-invasive Analyte Detection via Magnetic Particle Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting analytes in blood are invasive, inconvenient, and often require large sample volumes, struggling with low signal-to-noise ratios, especially for rare or small analytes like circulating tumor cells, which limits their sensitivity and specificity.

Innovation Solution

A system using functionalized particles that interact with target analytes, a magnetic field to modulate their spatial arrangement, and a processor to differentiate analyte response signals from background noise, enabling non-invasive, real-time detection of analytes in blood.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional sensing techniques are used to detect analytes in blood, then the detection method is simple and widely available, but the sensitivity is insufficient for rare analytes like circulating tumor cells

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the detection task by using functionalized particles to specifically bind to target analytes, separating the rare analyte signal from the complex blood matrix. This allows selective detection of circulating tumor cells or other rare analytes amidst billions of other blood components, dramatically improving detection sensitivity without requiring analysis of entire blood samples.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Functionalized particles serve as intermediaries between the target analytes and the detection system. These particles are engineered with specific binding moieties that recognize and bind to rare analytes, concentrating them and providing a detectable signal. This intermediary approach enables detection of analytes at concentrations far below what conventional methods can achieve.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If large quantities of blood are sampled to detect rare analytes with statistical significance, then the detection sensitivity improves, but the invasiveness and patient compliance requirements worsen

Engineering Contradiction:
Improvedetection sensitivityVSAvoidpatient compliance
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The system segments the detection approach by using functionalized particles that specifically target rare analytes, enabling detection from small blood volumes. This eliminates the need to process large quantities of blood, making the procedure less invasive and improving patient compliance while maintaining high detection sensitivity through selective particle-analyte binding.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system changes the detection parameter from bulk blood analysis to particle-bound analyte detection. By attaching detection moieties to functionalized particles that bind specifically to rare analytes, the system achieves high sensitivity in minimal sample volumes, transforming the detection approach from volume-dependent to affinity-dependent detection.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If fluorescence detection techniques are used to measure target analytes, then the detection capability is enhanced, but the background noise from other tissues and molecules increases

Engineering Contradiction:
Improveanalyte detection capabilityVSAvoidbackground noise
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The system extracts the target analyte signal from the background by using functionalized particles with specific binding affinity. The particles selectively bind to rare analytes, physically separating them from the fluorescent background of other tissues and molecules. This extraction approach allows fluorescence detection to proceed with minimal background interference, as only particle-bound analytes contribute to the specific signal.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system applies local quality by endowing functionalized particles with specific binding properties that recognize only target analytes. This localized specificity ensures that fluorescence signals originate only from particle-analyte complexes rather than from surrounding tissues or non-specific fluorescent molecules, dramatically improving signal-to-noise ratio through spatial and chemical selectivity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for non-invasive, real-time, high-density measurements of physiological parameters, improving the detection of rare analytes with enhanced sensitivity and specificity, reducing the need for large sample volumes and invasive procedures.

Implementation Method 1

a magnetic field source sufficient to distribute the magnetic particles into a spatial arrangement in the environment

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

a processor configured to non-invasively detect the one or more target analytes by differentiating the analyte response signal from the background signal, at least in part, based on modulation of the signals due, at least in part, to the spatial arrangement of the magnetic particles

Methodology Applied
Scientific EffectSignal modulation:

Data Source

PatentEP3060125B1Non-invasive analyte detection system with modulation source
Publication Date: 2020.04.08 VERILY LIFE SCIENCES LLC
  • EP3060125B1 patent drawingFigure 1
  • EP3060125B1 patent drawingFigure 2A~2B
  • EP3060125B1 patent drawingFigure 3A~3B

AI summary

A system for modulating a response signal includes functionalized particles configured to interact with target analytes, a detector configured to detect an analyte response signal transmitted from the body, a modulation source configured to modulate the analyte response signal, and a processor configured to non-invasively detect the one or more target analytes by differentiating the analyte response signal from a background signal, at least in part, based on the modulation. The analyte response signal is related to the interaction of the target analytes with the functionalized particles. In some examples, the system may also include magnetic particles and a magnetic field source sufficient to distribute the magnetic particles into a spatial arrangement in the body. The analyte response signal may be differentiated from the background signal, at least in part, based on modulation of the signals due, at least in part, to the spatial arrangement of the magnetic particles.